{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:24:13Z","timestamp":1795026253213,"version":"4.10.2"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11030-025-11165-y","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T14:59:16Z","timestamp":1743001156000},"page":"327-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacophore modeling and molecular dynamics simulations to study the conformational stability of natural HER2 inhibitors in breast cancer therapy"],"prefix":"10.1007","volume":"30","author":[{"given":"Kanchan Lata","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek Dhar","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himani","family":"Badoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"11165_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H et al (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast Off J Eur Soc Mastol 66:15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010","journal-title":"Breast Off J Eur Soc Mastol"},{"key":"11165_CR2","doi-asserted-by":"publisher","first-page":"1270877","DOI":"10.3389\/fonc.2023.1270877","volume":"13","author":"P Contiero","year":"2023","unstructured":"Contiero P, Boffi R, Borgini A et al (2023) Causes of death in women with breast cancer: a risks and rates study on a population-based cohort. Front Oncol 13:1270877. https:\/\/doi.org\/10.3389\/fonc.2023.1270877","journal-title":"Front Oncol"},{"key":"11165_CR3","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers13174287","volume":"13","author":"S \u0141ukasiewicz","year":"2021","unstructured":"\u0141ukasiewicz S, Czeczelewski M, Forma A et al (2021) Breast cancer\u2014epidemiology, risk factors, classification, prognostic markers, and current treatment strategies\u2014an updated review. Cancers 13:4287. https:\/\/doi.org\/10.3390\/cancers13174287","journal-title":"Cancers"},{"key":"11165_CR4","unstructured":"WHO Cancer"},{"key":"11165_CR5","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211033","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson L, Gathani T (2022) Understanding breast cancer as a global health concern. Br J Radiol. https:\/\/doi.org\/10.1259\/bjr.20211033","journal-title":"Br J Radiol"},{"key":"11165_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr3138","volume":"14","author":"J Kotsopoulos","year":"2012","unstructured":"Kotsopoulos J et al (2012) Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 14:1\u20137","journal-title":"Breast Cancer Res"},{"key":"11165_CR7","doi-asserted-by":"publisher","first-page":"e44081","DOI":"10.7759\/cureus.44081","volume":"15","author":"M Abraham","year":"2023","unstructured":"Abraham M, Lak MA, Gurz D et al (2023) A narrative review of breastfeeding and its correlation with breast cancer: current understanding and outcomes. Cureus 15:e44081. https:\/\/doi.org\/10.7759\/cureus.44081","journal-title":"Cureus"},{"key":"11165_CR8","first-page":"1568","volume":"10","author":"FZ Francies","year":"2020","unstructured":"Francies FZ, Hull R, Khanyile R, Dlamini Z (2020) Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options. Am J Cancer Res 10:1568\u20131591","journal-title":"Am J Cancer Res"},{"key":"11165_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/595167","volume":"2010","author":"LN Shulman","year":"2010","unstructured":"Shulman LN, Willett W, Sievers A, Knaul FM (2010) Breast Cancer in developing countries: opportunities for improved survival. J Oncol 2010:595167. https:\/\/doi.org\/10.1155\/2010\/595167","journal-title":"J Oncol"},{"key":"11165_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/CPath.S31563","volume":"8","author":"J Makki","year":"2015","unstructured":"Makki J (2015) Diversity of breast carcinoma: histological subtypes and clinical relevance. Clin Med Insights Pathol 8:23\u201331. https:\/\/doi.org\/10.4137\/CPath.S31563","journal-title":"Clin Med Insights Pathol"},{"key":"11165_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin L, Duan J-J, Bian X-W, Yu S (2020) Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res 22:61. https:\/\/doi.org\/10.1186\/s13058-020-01296-5","journal-title":"Breast Cancer Res"},{"key":"11165_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/JOC.JOC_117_18","volume":"36","author":"IM Francis","year":"2019","unstructured":"Francis IM, Altemaimi RA, Al-Ayadhy B et al (2019) Hormone receptors and human epidermal growth factor (HER2) expression in fine-needle aspirates from metastatic breast carcinoma \u2013 role in patient management. J Cytol 36:94\u2013100. https:\/\/doi.org\/10.4103\/JOC.JOC_117_18","journal-title":"J Cytol"},{"key":"11165_CR13","doi-asserted-by":"publisher","first-page":"26560","DOI":"10.18632\/oncotarget.5306","volume":"6","author":"G Palma","year":"2015","unstructured":"Palma G, Frasci G, Chirico A et al (2015) Triple negative breast cancer: looking for the missing link between biology and treatments. Oncotarget 6:26560\u201326574","journal-title":"Oncotarget"},{"key":"11165_CR14","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1111\/j.1582-4934.2009.00906.x","volume":"13","author":"FC Geyer","year":"2009","unstructured":"Geyer FC, Lopez-Garcia MA, Lambros MB, Reis-Filho JS (2009) Genetic characterization of breast cancer and implications for clinical management. J Cell Mol Med 13:4090\u20134103. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00906.x","journal-title":"J Cell Mol Med"},{"key":"11165_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.humpath.2004.11.010","volume":"36","author":"DG Hicks","year":"2005","unstructured":"Hicks DG, Tubbs RR (2005) Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines. Hum Pathol 36:250\u2013261. https:\/\/doi.org\/10.1016\/j.humpath.2004.11.010","journal-title":"Hum Pathol"},{"key":"11165_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41421-023-00523-5","volume":"9","author":"X Bai","year":"2023","unstructured":"Bai X, Sun P, Wang X et al (2023) Structure and dynamics of the EGFR\/HER2 heterodimer. Cell Discov 9:18. https:\/\/doi.org\/10.1038\/s41421-023-00523-5","journal-title":"Cell Discov"},{"key":"11165_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038508","volume":"103","author":"L Pan","year":"2024","unstructured":"Pan L, Li J, Xu Q et al (2024) HER2\/PI3K\/AKT pathway in HER2-positive breast cancer: a review. Medicine (Baltimore) 103:e38508. https:\/\/doi.org\/10.1097\/MD.0000000000038508","journal-title":"Medicine (Baltimore)"},{"key":"11165_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/852748","volume":"2014","author":"N Iqbal","year":"2014","unstructured":"Iqbal N, Iqbal N (2014) Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications. Mol Biol Int 2014:1\u20139. https:\/\/doi.org\/10.1155\/2014\/852748","journal-title":"Mol Biol Int"},{"issue":"6","key":"11165_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3389\/fonc.2022.819128","volume":"5","author":"Y Peng","year":"2022","unstructured":"Peng Y, Wang Y, Zhou C et al (2022) Frontiers | PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway? Front Oncol 5(6):546. https:\/\/doi.org\/10.3389\/fonc.2022.819128","journal-title":"Front Oncol"},{"key":"11165_CR20","unstructured":"Evaluation of PIK3CA mutations in advanced ER+\/HER2-breast cancer in Portugal \u2013 U-PIK Project - PMC. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9941536\/. Accessed 10 Oct 2024"},{"key":"11165_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1053\/j.seminoncol.2024.01.002","volume":"50","author":"D Wekking","year":"2023","unstructured":"Wekking D, Lambertini M, Dess\u00ec M et al (2023) CDK4\/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety. Semin Oncol 50:131\u2013139. https:\/\/doi.org\/10.1053\/j.seminoncol.2024.01.002","journal-title":"Semin Oncol"},{"key":"11165_CR22","doi-asserted-by":"publisher","first-page":"104694","DOI":"10.1016\/j.compbiomed.2021.104694","volume":"136","author":"SS Antunes","year":"2021","unstructured":"Antunes SS, Won-Held Rabelo V, Romeiro NC (2021) Natural products from Brazilian biodiversity identified as potential inhibitors of PknA and PknB of M. tuberculosis using molecular modeling tools. Comput Biol Med 136:104694. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104694","journal-title":"Comput Biol Med"},{"issue":"1","key":"11165_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13321-020-00478-9","volume":"13","author":"M Sorokina","year":"2021","unstructured":"Sorokina M et al (2021) COCONUT online: collection of open natural products database. J Cheminform 13(1):2","journal-title":"J Cheminform"},{"key":"11165_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/metabo2020303","volume":"2","author":"DA Dias","year":"2012","unstructured":"Dias DA, Urban S, Roessner U (2012) A historical overview of natural products in drug discovery. Metabolites 2:303\u2013336. https:\/\/doi.org\/10.3390\/metabo2020303","journal-title":"Metabolites"},{"key":"11165_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z et al (2000) The protein data bank. Nucleic Acids Res 28:235\u2013242","journal-title":"Nucleic Acids Res"},{"key":"11165_CR26","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s43018-022-00412-y","volume":"3","author":"B Wilding","year":"2022","unstructured":"Wilding B, Scharn D, Boese D et al (2022) Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling. Nat Cancer 3:821\u2013836","journal-title":"Nat Cancer"},{"key":"11165_CR27","doi-asserted-by":"publisher","first-page":"D198","DOI":"10.1093\/nar\/gkl999","volume":"35","author":"T Liu","year":"2007","unstructured":"Liu T, Lin Y, Wen X et al (2007) BindingDB: a web-accessible database of experimentally determined protein\u2013ligand binding affinities. Nucleic Acids Res 35:D198\u2013D201. https:\/\/doi.org\/10.1093\/nar\/gkl999","journal-title":"Nucleic Acids Res"},{"key":"11165_CR28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Knoll EH et al (2006) PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1 methodology and preliminary results. J Comput Aided Mol Des 20:647\u2013671","journal-title":"J Comput Aided Mol Des"},{"key":"11165_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","volume":"67","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Rao SN (2006) PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chem Biol Drug Des 67:370\u2013372","journal-title":"Chem Biol Drug Des"},{"key":"11165_CR30","unstructured":"Release S (2023) 2: Phase, Schr\u00f6dinger, LLC, New York, NY, 2023"},{"key":"11165_CR31","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749","journal-title":"J Med Chem"},{"key":"11165_CR32","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP et al (2006) Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212 ligand complexes. J Med Chem 49:6177\u20136196","journal-title":"J Med Chem"},{"key":"11165_CR33","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750\u20131759","journal-title":"J Med Chem"},{"key":"11165_CR34","unstructured":"Release S (2023) 2: Prime, Schr\u00f6dinger, LLC, New York, NY"},{"key":"11165_CR35","unstructured":"Lipinski\u2019s Rule of Five - an overview | ScienceDirect Topics. https:\/\/www.sciencedirect.com\/topics\/pharmacology-toxicology-and-pharmaceutical-science\/lipinskis-rule-of-five. Accessed 2 Jan 2024"},{"key":"11165_CR36","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"PC Agu","year":"2023","unstructured":"Agu PC, Afiukwa CA, Orji OU et al (2023) Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep 13:13398. https:\/\/doi.org\/10.1038\/s41598-023-40160-2","journal-title":"Sci Rep"},{"key":"11165_CR37","unstructured":"Desmond | Schr\u00f6dinger. https:\/\/www.schrodinger.com\/products\/desmond. Accessed 6 Oct 2023"},{"key":"11165_CR38","volume-title":"Schr\u00f6dinger Release 2018 4: desmond molecular dynamics system","author":"L Schr\u00f6dinger","year":"2018","unstructured":"Schr\u00f6dinger L (2018) Schr\u00f6dinger Release 2018 4: desmond molecular dynamics system. DE Shaw Research, New York"},{"key":"11165_CR39","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L (2001) Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A 105:9954\u20139960","journal-title":"J Phys Chem A"},{"key":"11165_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder E, Damm W, Maple J et al (2016) OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput 12:281\u2013296. https:\/\/doi.org\/10.1021\/acs.jctc.5b00864","journal-title":"J Chem Theory Comput"},{"key":"11165_CR41","first-page":"3525","volume":"5","author":"B Jaidhan","year":"2014","unstructured":"Jaidhan B, Rao PS, Apparao A (2014) Energy minimization and conformation analysis of molecules using steepest descent method. Int J Comput Sci Inf Technol 5:3525\u20133528","journal-title":"Int J Comput Sci Inf Technol"},{"key":"11165_CR42","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1063\/1.449071","volume":"83","author":"DJ Evans","year":"1985","unstructured":"Evans DJ, Holian BL (1985) The nose-hoover thermostat. J Chem Phys 83:4069\u20134074. https:\/\/doi.org\/10.1063\/1.449071","journal-title":"J Chem Phys"},{"issue":"12","key":"11165_CR43","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1021\/acs.jctc.5b00748","volume":"11","author":"SMJ Rogge","year":"2015","unstructured":"Rogge SMJ, Vanduyfhuys L, Ghysels A et al (2015) A Comparison of barostats for the mechanical characterization of metal-organic frameworks. J Chem Theory Comput 11(12):5583\u20135597","journal-title":"J Chem Theory Comput"},{"key":"11165_CR44","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1063\/1.470043","volume":"103","author":"HG Petersen","year":"1995","unstructured":"Petersen HG (1995) Accuracy and efficiency of the particle mesh Ewald method. J Chem Phys 103:3668\u20133679. https:\/\/doi.org\/10.1063\/1.470043","journal-title":"J Chem Phys"},{"key":"11165_CR45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"key":"11165_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2020.107322","volume":"87","author":"LP Kagami","year":"2020","unstructured":"Kagami LP, Das Neves GM, Timmers LFSM et al (2020) Geo-measures: a PyMOL plugin for protein structure ensembles analysis. Comput Biol Chem 87:107322. https:\/\/doi.org\/10.1016\/j.compbiolchem.2020.107322","journal-title":"Comput Biol Chem"},{"key":"11165_CR47","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) Pymol: an open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr 40:82\u201392","journal-title":"CCP4 Newsl Protein Crystallogr"},{"key":"11165_CR48","first-page":"1","volume":"420","author":"D Studio","year":"2008","unstructured":"Studio D (2008) Discovery studio. Accelrys 420:1\u20139","journal-title":"Accelrys"},{"key":"11165_CR49","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1038\/s41598-024-54281-9","volume":"14","author":"S Yang","year":"2024","unstructured":"Yang S, Kar S (2024) Protracted molecular dynamics and secondary structure introspection to identify dual-target inhibitors of Nipah virus exerting approved small molecules repurposing. Sci Rep 14:3696. https:\/\/doi.org\/10.1038\/s41598-024-54281-9","journal-title":"Sci Rep"},{"key":"11165_CR50","doi-asserted-by":"publisher","first-page":"14179","DOI":"10.1038\/s41598-023-40818-x","volume":"13","author":"M Rahimi","year":"2023","unstructured":"Rahimi M, Taghdir M, Abasi Joozdani F (2023) Dynamozones are the most obvious sign of the evolution of conformational dynamics in HIV-1 protease. Sci Rep 13:14179. https:\/\/doi.org\/10.1038\/s41598-023-40818-x","journal-title":"Sci Rep"},{"key":"11165_CR51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov MY, Bogatyreva N, Galzitskaya O (2008) Radius of gyration as an indicator of protein structure compactness. Mol Biol 42:623\u2013628","journal-title":"Mol Biol"},{"key":"11165_CR52","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.3390\/nano13172476","volume":"13","author":"PA Cavallaro","year":"2023","unstructured":"Cavallaro PA, De Santo M, Belsito EL et al (2023) Peptides targeting HER2-positive breast cancer cells and applications in tumor imaging and delivery of chemotherapeutics. Nanomaterials 13:2476. https:\/\/doi.org\/10.3390\/nano13172476","journal-title":"Nanomaterials"},{"key":"11165_CR53","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","volume":"616","author":"AV Sadybekov","year":"2023","unstructured":"Sadybekov AV, Katritch V (2023) Computational approaches streamlining drug discovery. Nature 616:673\u2013685. https:\/\/doi.org\/10.1038\/s41586-023-05905-z","journal-title":"Nature"},{"key":"11165_CR54","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/ph15050646","volume":"15","author":"D Giordano","year":"2022","unstructured":"Giordano D, Biancaniello C, Argenio MA, Facchiano A (2022) Drug design by pharmacophore and virtual screening approach. Pharmaceuticals 15:646. https:\/\/doi.org\/10.3390\/ph15050646","journal-title":"Pharmaceuticals"},{"key":"11165_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1501240","volume":"2","author":"D Chen","year":"2016","unstructured":"Chen D, Oezguen N, Urvil P et al (2016) Regulation of protein-ligand binding affinity by hydrogen bond pairing. Sci Adv 2:e1501240. https:\/\/doi.org\/10.1126\/sciadv.1501240","journal-title":"Sci Adv"},{"key":"11165_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2023.103753","volume":"30","author":"ZK Bagewadi","year":"2023","unstructured":"Bagewadi ZK, Yunus Khan TM, Gangadharappa B et al (2023) Molecular dynamics and simulation analysis against superoxide dismutase (SOD) target of Micrococcus luteus with secondary metabolites from Bacillus licheniformis recognized by genome mining approach. Saudi J Biol Sci 30:103753. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103753","journal-title":"Saudi J Biol Sci"},{"key":"11165_CR57","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1021\/acs.jpcb.6b11696","volume":"121","author":"K Moritsugu","year":"2017","unstructured":"Moritsugu K, Terada T, Kidera A (2017) Free-energy landscape of protein-ligand interactions coupled with protein structural changes. J Phys Chem B 121:731\u2013740. https:\/\/doi.org\/10.1021\/acs.jpcb.6b11696","journal-title":"J Phys Chem B"},{"key":"11165_CR58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/minf.201100135","volume":"31","author":"N Homeyer","year":"2012","unstructured":"Homeyer N, Gohlke H (2012) Free energy calculations by the molecular mechanics Poisson\u2212 Boltzmann surface area method. Mol Inform 31:114\u2013122","journal-title":"Mol Inform"},{"key":"11165_CR59","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","volume":"15","author":"S-Y Yang","year":"2010","unstructured":"Yang S-Y (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today 15:444\u2013450. https:\/\/doi.org\/10.1016\/j.drudis.2010.03.013","journal-title":"Drug Discov Today"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11165-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11165-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11165-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T15:56:25Z","timestamp":1771775785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11165-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11165"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11165-y","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"2 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}